- Home
- CRDF vs SILC Comparison
CRDF vs SILC Comparison
Compare CRDF & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDF | SILC |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.5M | 110.7M |
| IPO Year | 2012 | 2002 |
Fundamental Metrics
Financial Performance| Metric | CRDF | SILC |
|---|---|---|
| Price | $1.93 | $19.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $9.63 | N/A |
| AVG Volume (30 Days) | ★ 989.3K | 69.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $365,993.00 | N/A |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $12.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 49.61 | N/A |
| 52 Week Low | $1.48 | $12.44 |
| 52 Week High | $4.56 | $23.00 |
Technical Indicators
Market Signals| Indicator | CRDF | SILC |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 54.54 |
| Support Level | $1.48 | $14.34 |
| Resistance Level | $2.41 | $20.73 |
| Average True Range (ATR) | 0.11 | 1.24 |
| MACD | 0.08 | -0.21 |
| Stochastic Oscillator | 78.64 | 48.64 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.